G&S Capital LLC Novartis Ag Transaction History

G&S Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 24, 2020	SELL	$80.93 - $91.1 $8,497 - $9,565	-105 Closed	0 $0
Q1 2020 Apr 23, 2020	SELL	$70.67 - $99.01 $3 Million - $4.2 Million	-42,463 Reduced 99.75%	105 $8,000
Q4 2019 Jan 21, 2020	SELL	$84.35 - $95.37 $29,522 - $33,379	-350 Reduced 0.82%	42,568 $4.03 Million
Q3 2019 Oct 17, 2019	BUY	$85.54 - $94.26 $222,061 - $244,698	2,596 Added 6.44%	42,918 $3.73 Million
Q2 2019 Jul 19, 2019	BUY	$75.4 - $92.8 $1.62 Million - $2 Million	21,502 Added 114.25%	40,322 $3.68 Million
Q1 2019 Apr 22, 2019	BUY	$75.32 - $86.15 $1.41 Million - $1.61 Million	18,721 Added 18910.1%	18,820 $1.81 Million
Q4 2018 Jan 15, 2019	BUY	$73.66 - $82.02 $7,292 - $8,119	99 New	99 $8,000

1,434

138M

1.48M

1.55M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $236B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of G&S Capital LLC, based on Form 13F filings with the SEC.

Stay updated on G&S Capital LLC with notifications on news.